Health

  • Home
  • Business
    • Internet
    • Market
    • Stock
  • Parent Category
    • Child Category 1
      • Sub Child Category 1
      • Sub Child Category 2
      • Sub Child Category 3
    • Child Category 2
    • Child Category 3
    • Child Category 4
  • Featured
  • Health
    • Childcare
    • Doctors
  • Home
  • Business
    • Internet
    • Market
    • Stock
  • Downloads
    • Dvd
    • Games
    • Software
      • Office
  • Parent Category
    • Child Category 1
      • Sub Child Category 1
      • Sub Child Category 2
      • Sub Child Category 3
    • Child Category 2
    • Child Category 3
    • Child Category 4
  • Featured
  • Health
    • Childcare
    • Doctors
  • Uncategorized

Friday, January 6, 2023

FDA accelerates approval for Alzheimer’s drug

 January 06, 2023     Health, Health News Today on Fox News     No comments   

The Food and Drug Administration on Friday announced the fast-tracked approval of an Alzheimer’s drug that modestly slows the brain-robbing disease to those with mild impairment.

The drug, Leqembi, is the first that’s been convincingly shown to slow the decline in memory and thinking that defines Alzheimer’s by targeting the disease's underlying biology. The FDA approved it for patients with Alzheimer's, specifically those with mild or early-stage disease.

The approval came after clinical trials that showed the drug slows cognitive decline but also carries the risk of brain swelling and bleeding.

ALZHEIMER'S EXPERIMENTAL DRUG MAY SLOW PROGRESSION OF DISEASE, BUT THERE ARE RISKS: EXPERTS

"Alzheimer’s disease immeasurably incapacitates the lives of those who suffer from it and has devastating effects on their loved ones," said Billy Dunn, M.D., director of the Office of Neuroscience in the FDA’s Center for Drug Evaluation and Research. "This treatment option is the latest therapy to target and affect the underlying disease process of Alzheimer’s, instead of only treating the symptoms of the disease."

Leqembi was developed by Japan's Eisai and its U.S. partner Biogen. Eisai is pricing the drug at $26,500 annually per patient.

Eisai executives said they have already spent months discussing their drug's data with Medicare officials. Coverage isn't expected until after the FDA confirms the drug's benefit, likely later this year.

The FDA approval came through its accelerated pathway, a shortcut that allows drugs to be launched based on early results. Despite the approval, the pathway has come under criticism. 

A congressional report released last week found that the FDA's approval of another Alzheimer's drug called Aduhelm — also from Biogen and Eisai — was "rife with irregularities," including a number of meetings with drug company staffers that went undocumented.

About 13% of patients in Eisai’s study had swelling of the brain and 17% had small brain bleeds, side effects seen with earlier amyloid-targeting medications. In most cases, those problems didn’t cause symptoms, which can include dizziness and vision problems.

Also, several Leqembi users died while taking the drug, including two who were on blood-thinning medications. Eisai has said the deaths can’t be attributed to the drug. The FDA label warns doctors to use caution if they prescribe Leqembi to patients on blood thinners.

More than 6.5 million Americans age 65 or older are living with dementia due to Alzheimer's, according to the Alzheimer’s Association.

The Associated Press contributed to this report. 



from Health News Today on Fox News https://ift.tt/gxXBezI
  • Share This:  
  •  Facebook
  •  Twitter
  •  Google+
  •  Stumble
  •  Digg
Email ThisBlogThis!Share to XShare to Facebook

Related Posts:

  • Sweden reports first case of highly-infectious mpox virus outside Africa amid outbreak thereSwedish health authorities announced the first case of the highly-infectious mpox just a day after the World Health Organization declared a global eme… Read More
  • Men's cancer warnings, rare diseases revealed, and babies' chiropractic careCONTROVERSIAL ‘CURE’ – Doctors clash on the safety of chiropractic care for babies, as one family claims that adjustments transformed their fussy newb… Read More
  • Ohio baby ‘smiling again’ after chiropractic adjustments, parents say — but is it safe?A newborn in Columbus, Ohio, has a brand new demeanor ever since being treated by a chiropractor, her parents say. Lily Freeman, just 2 months old, wa… Read More
  • 'I feel a migraine coming on, what can I do right away?': Ask a doctorPeople who suffer from migraines — one out of every seven people globally, statistics show — know that time is of the essence. When the first signs an… Read More
  • 'Gender-affirming' breast removal surgeries may have been performed on hundreds of young girls since 2017Since 2017, hundreds of females age 12 and younger with gender dysmorphia have undergone double mastectomies, according to analysis released by the Ma… Read More
Newer Post Older Post Home

0 comments:

Post a Comment

Popular Posts

  • Ozempic ‘microdosing’ is the new weight-loss trend: Should you try it?
    A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. With approximately 70% of...
  • Helping Stroke Patients Regain Movement in their Hands
    By BY PAM BELLUCK from NYT Health https://ift.tt/6uNPHMD
  • As eating disorders increase among college students, here's how parents can help: ‘Early intervention is key’
    While most of us have heard about the "Freshman 15" — the stereotypical first-year weight gain among college students — a growing ...

Recent Posts

Categories

  • Health News Today on Fox News
  • FOX NEWS
  • Fox News : Health
  • Health
  • Health News Today on Fox News
  • Healthy tips
  • NYT

Unordered List

Pages

  • Home

Text Widget

Blog Archive

  • July 2025 (18)
  • June 2025 (75)
  • May 2025 (88)
  • April 2025 (84)
  • March 2025 (88)
  • February 2025 (70)
  • January 2025 (72)
  • December 2024 (81)
  • November 2024 (70)
  • October 2024 (82)
  • September 2024 (75)
  • August 2024 (82)
  • July 2024 (79)
  • June 2024 (74)
  • May 2024 (73)
  • April 2024 (78)
  • March 2024 (75)
  • February 2024 (78)
  • January 2024 (78)
  • December 2023 (60)
  • November 2023 (80)
  • October 2023 (74)
  • September 2023 (75)
  • August 2023 (85)
  • July 2023 (67)
  • June 2023 (58)
  • May 2023 (100)
  • April 2023 (105)
  • March 2023 (118)
  • February 2023 (84)
  • January 2023 (87)
  • December 2022 (69)
  • November 2022 (64)
  • October 2022 (78)
  • September 2022 (74)
  • August 2022 (110)
  • July 2022 (109)
  • June 2022 (127)
  • May 2022 (95)
  • April 2022 (109)
  • March 2022 (140)
  • February 2022 (138)
  • January 2022 (170)
  • December 2021 (182)
  • November 2021 (213)
  • October 2021 (506)
  • September 2021 (539)
  • August 2021 (564)
  • July 2021 (590)
  • June 2021 (556)
  • May 2021 (544)
  • April 2021 (310)
  • March 2021 (331)
  • February 2021 (301)
  • January 2021 (326)
  • December 2020 (521)
  • November 2020 (403)
  • October 2020 (537)
  • September 2020 (554)
  • August 2020 (431)
  • July 2020 (647)
  • June 2020 (610)
  • May 2020 (659)
  • April 2020 (681)
  • March 2020 (729)
  • February 2020 (564)
  • January 2020 (483)
  • December 2019 (396)
  • November 2019 (416)
  • October 2019 (526)
  • September 2019 (486)
  • August 2019 (441)
  • July 2019 (394)
  • June 2019 (381)
  • May 2019 (510)
  • April 2019 (471)
  • March 2019 (560)
  • February 2019 (403)
  • January 2019 (530)
  • December 2018 (382)
  • November 2018 (378)
  • October 2018 (510)
  • September 2018 (297)
Powered by Blogger.

Report Abuse

Formulir Kontak



Search This Blog

Find Us On Facebook

Labels

  • Health News Today on Fox News
  • FOX NEWS
  • Fox News : Health
  • Health
  • Health News Today on Fox News
  • Healthy tips
  • NYT

Flickr Images

Most Popular

  • Ozempic ‘microdosing’ is the new weight-loss trend: Should you try it?
    A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. With approximately 70% of...
  • Helping Stroke Patients Regain Movement in their Hands
    By BY PAM BELLUCK from NYT Health https://ift.tt/6uNPHMD
  • As eating disorders increase among college students, here's how parents can help: ‘Early intervention is key’
    While most of us have heard about the "Freshman 15" — the stereotypical first-year weight gain among college students — a growing ...
  • Pioneer of America's global HIV/AIDS program recalls hope after years of despair
    Through his office window at what was then one of Africa's few modern clinics dealing with HIV and AIDS , the man who now oversees the U...
  • Free COVID tests will again be available from US government starting next week
    The U.S. government is reactivating the program that mails free COVID-19 tests to Americans' homes upon request. Effective Sept. 25, h...
  • FOX NEWS: Woman’s ‘baby bump’ turns out to be two ovarian tumors
    Woman’s ‘baby bump’ turns out to be two ovarian tumors A 49-year-old woman who struggled with fertility thought she might be pregnant w...
  • New COVID vaccine push is ‘anti-human,’ says Florida surgeon general: ‘Major safety concern’
    The new COVID-19 vaccine is now available at participating pharmacies and health care providers, and the Centers for Disease Control (CDC) ...
  • AI tech aims to help patients catch disease early even reverse their biological age
    In humanity's quest to live longer, healthier lives, technology — particularly artificial intelligence — is playing an ever-bigger role...
  • US scores D+ for preterm birth rates, says new report: ‘Falling further behind’
    The rate of preterm births remains alarmingly high in the U.S., according to the latest March of Dimes Report Card. The figure was around ...
  • FOX NEWS: Vermont fertility doctor accused of using his own sperm to inseminate woman 41 years ago: lawsuit
    Vermont fertility doctor accused of using his own sperm to inseminate woman 41 years ago: lawsuit A child conceived in 1977 through art...

Sample Text

Copyright © 2025 Health | Powered by Blogger
Design by Hardeep Asrani | Blogger Theme by NewBloggerThemes.com | Distributed By Gooyaabi Templates